The Price Is Public. The Point Is Not.

There's a line in National Defence's proactive disclosure that doesn't read the way you'd expect. The department signed a contract worth $745,939.37 — call it three-quarters of a million dollars — for the "rental of industrial and commercial buildings." Nothing strange there on its own; the military leases space across the country. The strange part is who collected the cheque.

The vendor is Innomar Strategies Inc., and Innomar is not a landlord. It's a pharmaceutical company.

Founded in Oakville, Ontario in 2001, Innomar runs patient support programs, specialty pharmacy, nursing and clinical services, and third-party logistics — the unglamorous business of storing and shipping medication under strict, temperature-controlled, GMP-compliant conditions. Since 2009 it has been a subsidiary of the American drug distributor AmerisourceBergen, now called Cencora, which bought the company for a reported $15 million CAD.

If Innomar's name rings a bell, it's probably from the pandemic. In December 2020 the firm partnered with FedEx Express Canada on a Government of Canada contract — reported at roughly $90.4 million — to store and distribute COVID-19 vaccines across the country. That work leaned on exactly what Innomar sells: cold-chain warehousing and the logistics to move sensitive cargo coast to coast to coast.

So a pharma-logistics company holding a federal contract is not, by itself, surprising. What's harder to square is the category. "Rental of industrial and commercial buildings" is a procurement bucket that usually points to space — warehouses, hangars, depots — not to vaccines or nursing services. The contract was competitively sourced, which is the procurement model taxpayers should want: it means more than one bidder had a shot, and the file wasn't quietly handed to a single supplier. It was awarded on August 15, 2025, and logged as a service contract.

Read together, the most ordinary explanation is the likeliest one — National Defence paying for industrial storage capacity, and a company that already runs GMP-compliant distribution hubs, including one in Milton, Ontario, being well placed to provide it. Medical supplies, after all, need somewhere climate-controlled to sit.

But "likeliest" is doing a lot of work in that sentence, because the public record stops at the disclosure line. Ottawasted could not independently verify what the $745,939.37 — a sum that would cover a year of rent for a dozen families priced out of the market — actually bought. There's no news coverage, no press release, no official write-up of this particular contract: just the category, the dollar figure, and the date.

That's the gap. Proactive disclosure exists so citizens can see where their money goes, but a one-line entry that pairs a drug-distribution firm with a real-estate category answers the "how much" without ever touching the "what for."

So the honest question here isn't whether anything went wrong — there's no evidence it did. It's narrower, and it's fair: when a federal department spends three-quarters of a million dollars, should a curious taxpayer have to guess what they got for it?

On May 22, 2025, the Department of National Defence signed a contract worth $3,689,635.95. The vendor was Deloitte Inc. The job, according to the federal contract record, was "Other professional services not elsewhere specified."

That last phrase is doing a lot of work. It's the government's catch-all category — the box you tick when the service doesn't fit any of the more specific labels. So we know almost $3.7 million changed hands. What we don't know, from the disclosure itself, is what Ottawa actually got for it.

Here's what we do know. Deloitte Inc. is the Canadian arm of one of the world's "Big Four" professional services networks — a global operation spanning more than 150 countries and roughly 470,000 employees. Deloitte Canada is among the largest firms of its kind in the country, selling audit, consulting, advisory and tax services. It also runs a dedicated defence and public-sector practice built specifically to serve National Defence and the Canadian Armed Forces. In other words, this is not a surprise pairing. Deloitte knows this customer well.

The contract was competitively sourced, awarded against what's called a Supply Arrangement — a pre-qualified pool of vendors the government can draw from without running a full open tender each time. That's a routine, legitimate mechanism. It speeds up procurement. It also means the competition happens inside a closed list of firms that already cleared the bar, rather than out in the open.

Translate the figure into something you can picture. $3.69 million is enough to cover a full year's rent for well over a hundred Canadian families — the kind of money that builds, or fails to build, real housing, sitting here inside a single consulting line item.

This isn't Deloitte's first defence file. The firm has previously been one of several — alongside McKinsey, IBM and Accenture — competitively engaged by National Defence to review the Defence Supply Chain. Consulting on the machinery of defence is, for Deloitte, a standing line of business.

And the scale is bigger than any one contract. In 2024, the Big Four firms — Deloitte among them — collectively pulled in roughly $240 million across about 200 federal contracts. That's the backdrop: a steady, structural reliance on outside consultants for work the public service could, in theory, do itself.

None of that makes this contract improper. It was competed. It went to a qualified firm with deep defence experience. The process, on paper, worked as designed.

The hard part is the disclosure. Proactive disclosure exists so taxpayers can see where their money goes. But "Other professional services not elsewhere specified" tells a reader almost nothing — not the deliverable, not the duration, not the problem being solved. The money is visible. The value is not.

So the open question isn't whether Deloitte should have been paid. It's this: when the public record won't say what $3.7 million bought, how is anyone outside the department supposed to judge whether it was worth it?

In March 2020, as the pandemic began shutting down the country, Global Affairs Canada signed off on a $20-million commitment. The money wasn't going to a Canadian hospital, a Canadian clinic, or a Canadian patient. It was headed to Ethiopia.

The recipient is Marie Stopes International Ltd., a London-based registered charity that provides contraception and abortion services in roughly 37 countries. It renamed itself MSI Reproductive Choices in November 2020, months after this deal was struck. The project has a plain enough name: "Safe Abortion, Contraception and Family Planning in Ethiopia." Every dollar — 100 per cent of the project's value — is directed to Ethiopia.

This is foreign aid, not a contract for goods or services delivered back home. It falls under Canada's Feminist International Assistance Policy, the framework Ottawa adopted to make support for family planning, contraception, and safe and legal abortion an explicit part of its foreign policy. Abortion, for the record, has been legal in Ethiopia under defined circumstances since the country reformed its Penal Code in 2005.

So what does $20 million buy? According to Canada's own Project Browser, the work is aimed squarely at rural Ethiopia — specifically married adolescent girls aged 15 to 19 and young women aged 20 to 24. The project runs community awareness programs, sends mobile outreach clinics into the countryside to offer family planning and post-abortion care, and trains health extension workers.

The numbers it reports are not small. As of September 2023, the project had trained 11,636 health workers and delivered 217,293 family planning and safe abortion services. The partner on the ground, Marie Stopes Ethiopia, isn't a newcomer — it was founded in 1990 and is described as one of the two largest NGOs providing sexual and reproductive health services in the entire country.

By the standards of international development, this is a fairly conventional arrangement: a maximum contribution paid out over five years, from March 2020 to June 2025, to an established charity with deep local infrastructure. Global Affairs routinely channels aid through NGOs rather than building its own clinics abroad, and Marie Stopes Ethiopia is about as established as a partner gets. The project is currently listed as operational.

What makes the file worth a second look isn't irregularity — it's scale and distance. Twenty million dollars is a real number. Spent at home, it would cover the down payment on a first home for hundreds of young Canadian families locked out of the housing market. Instead, by Ottawa's own design, it crosses an ocean.

That's not a scandal. It's a choice — a deliberate, published, policy-driven choice about what Canadian tax dollars are for. Successive governments have decided that funding reproductive health abroad serves Canada's interests and values. Voters get to decide whether they agree.

So here's the open question: when the federal government has a finite budget and a long line of competing needs, how much of it belongs overseas — and who should get a say in drawing that line?